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a b s t r a c t
Maintaining glucose levels within the appropriate physiological range is necessary for survival. The iden-
tiﬁcation of speciﬁc neuronal populations, within discreet brain regions, sensitive to changes in glucose
concentrationhas led to thehypothesis of a central glucose-sensing systemcapableofdirectlymodulating
feeding behaviour. Glucokinase (GK) has been identiﬁed as a glucose-sensor responsible for detect-
ing such changes both within the brain and the periphery. We previously reported that antagonism
of centrally expressed GK by administration of glucosamine (GSN) was sufﬁcient to induce protective
glucoprivic feeding in rats. Here we examine a neurochemical mechanism underlying this effect and
report that GSN stimulated food intake is highly correlated with the induction of the neuronal activa-
tionmarker cFOSwithin two nuclei with a demonstrated role in central glucose sensing and appetite, the
arcuate nucleus of the hypothalamus (ARC) and lateral hypothalamic area (LHA). Furthermore, GSN stim-europeptide Y
rexin
elanocyte-stimulating hormone
elanin concentrating hormone
ypothalamus
ulated cFOSwithin theARCwas observed in orexigenic neurons expressing the endogenousmelanocortin
receptor antagonist agouti-relatedpeptide (AgRP) andneuropeptideY (NPY), butnot those expressing the
anorectic endogenous melanocortin receptor agonist alpha-melanocyte stimulating hormone (-MSH).
In the LHA, GSN stimulated cFOS was found within arousal and feeding associated orexin/hypocretin
(ORX), but not orexigenic melanin-concentrating hormone (MCH) expressing neurons. Our data suggest
that GKwithin these speciﬁc feeding and arousal related populations of AgRP/NPY and ORX neuronsmay
the splay a modulatory role in
The detection and maintenance of physiologically appropriate
evels of glucose is paramount to mammalian viability. Multiple
hysiological systems, therefore, operate to detect ﬂuctuations in
lucose levels and to prompt the induction of apposite counter-
egulatory responses, including ingestivebehaviour.Glucose, as the
rimary fuel source in mammals, is a key indicator of nutritional
tate, with low or falling blood glucose levels triggering defensive
hysiological responsesandhunger.However, forglucose tobeable
o inﬂuence feeding behaviour, whether as an emergency response
o glucoprivation or within a more normal appetitive context, the
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brain must be able to accurately and rapidly detect oscillations in
interstitial glucose levels. In this regard, thehypothalamushasbeen
identiﬁed as a key component of the centrally regulated energy
homeostasis network.
Within the basomedial hypothalamus, themelanocortin system
in the arcuate nucleus (ARC) plays a critical role in energy bal-
ance; the orexigenic endogenousmelanocortin receptor antagonist
agouti-related peptide (AgRP) is co-expressedwith orexigenic neu-
ropeptide Y (NPY), while the anorectic endogenous melanocortin
receptor agonist alpha-melanocyte simulating hormone (-MSH)
is co-expressedwith anorectic cocaine andamphetamine regulated
transcript (CART) [1]. These basomedial populationsmay form part
of an integrated homeostatic network with neurons of the lateral
hypothalamic area (LHA) that express orexin/hypocretin (ORX) or
melanin concentrating hormone (MCH). In controlling energy bal-
ance, these neurons respond to a complex series of nutritional
cues, including those communicated by peripherally derived cir-
culating factors or relayed by visceral nerves. In addition, some
neurons are able to inﬂuence energy homeostasis in response to
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irectly sensed changes in the levels of speciﬁc brain substrates
ithin their local environment [2,3]. In this regard, AgRP/NPY, -
SH, ORX andMCHneurons sense changes in extracellular glucose
oncentration [4–8]. Such neurons can exhibit excitatory (glucose-
xcited, GE) or inhibitory (glucose-inhibited, GI) ﬁring responses to
ising glucose levels [3]. Indeed, approximately 40% of AgRP/NPY
xpressing neurons in the ARC and 90% of ORX neurons in the LHA
emonstrate hyperpolarisation on elevation of extracellular glu-
ose concentration [4,5]. Thus, activation of these neurons under
ypoglycaemic conditions is thought to induce counter-regulatory
esponses, including arousal and hunger symptoms aimed at stim-
lating a protective feeding reaction.
Although the mechanistic underpinnings of neuronal glucose
ensing remain poorly understood, it has been hypothesised that
heseneuronsmayemploya similarmechanismofdetection to that
een peripherally. The low afﬁnity hexokinase, glucokinase (GK),
atalyses the phosphorylation of glucose to glucose-6-phosphate,
ut in pancreatic -cells can also function as a glucose-sensor [9].
ore recently, GK has also been identiﬁed within the brain and
peciﬁcally in canonical glucose-sensitivenuclei, including theARC,
entromedial nucleus and dorsomedial nucleus of the hypotha-
amus [10–12]. In the ARC, GK has been identiﬁed in AgRP/NPY
nd -MSH/CART neurons [13]. Functional studies in hypothala-
ic neurons have shown that inhibition of GK function suppresses
ctivity and/or blocks the ability of glucose to stimulate GE neu-
ons and suppress GI neurons [14,15]. Indeed, recent studies have
emonstrated the importance of hypothalamicGK in themediation
f counter-regulatory responses to insulin-induced hypoglycaemia
16]. These data support the notion that GK represents a central
glucostat’ capable of regulating neuronal function, and down-
tream protective physiological responses.
Consistentwith this,we recently reported that intracerebroven-
ricular (i.c.v) infusion of GK inhibitors such as glucosamine (GSN)
17] resulted in a rapid stimulation of protective feeding in rats
18]. Here we examine the underlying mechanism of this effect
y assessing neuronal activation in chemically deﬁned neurons
nduced by central GSN administration under normoglycaemic
onditions.
Male Sprague–Dawley rats (Charles River) weighing 280–300g
ere individually housed with ad libitum access to water and stan-
ard laboratory chow (Eurodent Diet, PMI Nutrition International).
nimals were maintained in a light (12h on/12h off) and temper-
ture controlled environment (21.5–22.5 ◦C). All procedures used
ere in accordance with the guidelines for the care and use of
nimals established by the UK Animals (Scientiﬁc Procedures) Act
986.
Rats were anesthetized by intraperitoneal (i.p) administra-
ion of ketamine (100mg/kg, National Veterinary Supplies) and
ylazine (20mg/kg, National Veterinary Supplies) and a single-
uide cannula (Plastics One, VA) was inserted into the third
entricle (coordinates from bregma anteroposterior – 2.2mm, lat-
ral 0.9mm, dorsoventral 8.4mm) and cemented in place with
nchoring screws, as described previously [18]. Five to eight days
ost surgery, ad libitum fed animals received either aECF (n=7, CMA
icrodialysis AB distributed by Linton Instrumentation) or recom-
inant glucosamine (GSN;CMSChemicals 15or150nmol/min,n=4
nd 6, respectively) via the indwelling cannula for 60min, starting
t mid light cycle at an infusion rate of 0.3l/min, with a prim-
ng dose of 0.9l/min over the ﬁrst 3min. The GSN doses used
ere characterized in an earlier report [18]. Food intake was mea-
ured by weighing chow pellets two hours after the termination
f aECF or GSN infusion. Animals were then anesthetized with
etamine (100mg/kg i.p) and xylazine (20mg/kg i.p), and transcar-
ially perfused with diethylpyrocarbonate (DEPC; Sigma)-treated
.9% salinefollowed by phosphate-buffed 10% formalin, pH 7.0
Sigma). Brains were removed, post-ﬁxed in the same ﬁxative forsearch 222 (2011) 274–278 275
4h and then submerged overnight in 30% sucrose in DEPC-treated
phosphate-buffered saline (DEPC-PBS). Brains were cut on a freez-
ing microtome at 25m (1:6 series) and stored in an antifreeze
solution containing 30% ethylene glycol and 20% glycerol in DEPC-
PBS at −20 ◦C.
For quantitative assessment of neuronal activation, sectioned
tissue was processed for immunohistochemical detection of cFOS
immunoreactivty (FOS-IR). Each step listed below was preceded
by PBS rinses for 15min. Sections were pre-treated in 0.3% H2O2
(Sigma) for 1h, blocked in 0.3% normal donkey serum (Sigma) in
PBT (0.04% Triton X-100 (Sigma) in PBS) and then incubated with
rabbit anti-FOS antibody (Calbiochem; 1:10,000) in 0.3% normal
donkey serum and PBT-azide (0.02% sodium azide (Sigma) in PBT)
overnight at room temperature. Sections were then incubated for
1h with biotinylated donkey anti-rabbit serum (Jackson Laborato-
ries; 1:500) in 0.3% normal donkey serum and PBT and then with
avidin–biotin complex (ABC; Vector Elite kit; Vector laboratories;
1:250) in PBS for 1h. The immunoperoxidase was developed in
0.04% 3,3′-diaminobenzidine tetrahydrochloride (DAB; Sigma) and
0.003% hydrogen peroxide in PBS. Sections were mounted onto
polysine slides, air-dried for 30min, counter-stained in cresyl violet
(Sigma) for 1min and dehydrated in an ascending ethanol series,
before being cleared in xylene (VWR International) and cover-
slipped with mounting media (Micromount, Surgipath).
Subsequent chemical identiﬁcation of FOS-IR cellswas achieved
by dual-labelled immunoﬂuorescence analysis. Sections were
treated as described above and then incubated with goat anti-
cFOS antibody (Santa Cruz, 1:1,000) and either sheep anti--MSH
serum (Chemicon; 1:10,000), rabbit anti-ORX serum (Phoenix
Pharmaceuticals; 1:10,000), or rabbit anti-MCH serum (Phoenix
Pharmaceuticals; 1:10,000) in PBT overnight at room temper-
ature. Following this, tissue was incubated with biotinylated
donkeyanti-goat antibody (JacksonLaboratories; 1:500) for1h, fol-
lowed by incubation with Alexa Fluor-488 conjugated streptavidin
(Molecular Probes; 1:1000) and Alexa Fluor-594 conjugated don-
key anti-rabbit or anti-sheep (Molecular Probes; 1:1000) for 1h.
After mounting on polysine slides, the sections were coverslipped
with anti-fade mounting medium for ﬂuorescence (Vectashield,
Vector).
To investigate the colocalisation of cFOS and NPY, a modiﬁed
method combining immunoﬂuorescence and ﬂuorescent in situ
hybridization histochemistry (FISH) was used [19]. Tissue was
processed ﬁrst for FOS-IR as described above using RNase-free
methods. Following this, sections were rinsed thoroughly in PBS,
equilibrated in 5× sodium saline citrate (SSC) for 30min and
transfered to hybridization buffer (HB) [19] for 2h at 56 ◦C.
A digoxgenin-labelled riboprobe (DIG-NPY) was generated from
cDNA template speciﬁc to the rat NPY sequence by in vitro tran-
scription with T7 polymerase, as previously described [20]. The
DIG-labelled riboprobe (500ng) was heated to 90 ◦C in 100l
HB solution for 10min, placed on ice for 5min, and added to
the tissue/HB mix and incubated for 12 to 16hrs at 56 ◦C. Sec-
tions were then rinsed with 2× SSC and incubated with RNase A
(Boehringer–Mannheim) in 0.5MNaCl, 10mMTris–HCl, pH8.0 and
0.5M EDTA for 6min at 37 ◦C. The sections were washed in 2×
SSC for 1h at 65 ◦C, and in 0.2× SSC for 1h at 65 ◦C. After a brief
equilibration in a solution of 0.1M Tris–HCl, 0.1MNaCl and 50mM
MgCl2, pH 7.5 (GB1) at room temperature, the sections were trans-
ferred to blocking solution, containing 0.1M Tris–HCl, 0.15M NaCl
and 0.5% blocking regent (PerkinElmer). Immunological detection
of the DIG-NPY probe was achieved by incubating the sections in
GB1 solution containing sheep anti-DIG antibody (Roche, 1:100) at
room temperature overnight. The next day, following a rinse inGB1
and equilibration in 0.1M Tris–HCl, 0.15% NaCl and 0.05% Tween
20 (TNT), DIG-NPY was visualized by Cy3 ﬂuorophore tyramide
(PerkinElmer, 1:50) for 3–10min. Sections were brieﬂy washed in
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aig. 1. GSN signiﬁcantly increased food intake and FOS-IR in the ARC and LHA. (a) G
nd (c) LHA in rats compared to GSN (15nmol/min, i.c.v.) and aECF. *p≤0.05, **p≤
BS,mounted on superfrost slides, air-dried, and coverslippedwith
nti-fade mount medium for ﬂuorescence (Vectashield).
Sections from all experimentswere analysed and photographed
ith a Zeiss Axioskop 2 microscope and a Zeiss AxioCam HRc
igital camera. Neuroanatomical delineation of brain regions was
etermined fromcresyl violet counterstained sections. Immunoﬂu-
rescencewas observedwith appropriatemicroscope ﬁlter sets for
lexa Fluor-488, Alexa Fluor-594 and Cy3. All data are expressed
s mean± SEM and analysed statistically using t-test, one-way
NOVA followedbyTukey’spost hoc analysis,where appropriate, or
earsonProductMomentCorrelation (SPSSversion11.5). Statistical
igniﬁcance was assigned at p<0.05.
Third ventricular infusion of the GK inhibitor GSN
150nmol/min) rapidly and signiﬁcantly stimulated feeding
ompared to low dose GSN (15nmol/min) or aECF (F(2,10) =32.3,
< 0.0001; Fig. 1A). In a directly associated manner, GSN
150nmol/min) robustly induced FOS-IR in discrete brain regions
Supplemental Fig. S1). In particular, substantial GSN-induced FOS-
Rwas observed in the ARC (F(2,10) =186.5, p<0.0001; Fig. 1B) and
HA (F(2,10) =7.4, p<0.01; Fig. 1C). GSN also induced a smaller
ncrease in FOS-IR inmidline areas, particularly those related to the
utonomic system and connected regions in the forebrain, such as
idline thalamus, periaqueductal gray and ventral division of the
ed nucleus of the stria terminalis (Supplemental Fig. S1). Infusion
f aECF or the non-orexigenic dose of GSN (15nmol/min, data not
hown) induced little FOS-IR in the brain (Supplemental Fig. S2).
We further characterized the strength of the association
etween GSN-stimulated feeding and ARC and LHA FOS-IR induc-
ion by performing a correlation analysis. A high association was
ound; the greater the number of ARC and LHA neurons activated,
hemore effective GSNwas in stimulating food intake (ARC r =0.90,
< 0.001; LHA r=0.92, p<0.001).
Dual-neurohistochemical analysis was performed to determine
he chemical identity of GSN ARC and LHA activated neurons.
he ARC contains two distinct populations of energy homeostasis
elated neurons, those containing orexigenic NPY/AgRP and those
ig. 2. GSN signiﬁcantly activates ARC NPY and LHA ORX neurons, but not ARC -MSH or
han 1% of -MSH-IR neurons, but induced FOS-IR in approximately one-third of NPY neu
signiﬁcant increase in FOS-IR in ORX neurons. **p≤0.01, ***p≤0.001.0nmol/min, i.c.v.) signiﬁcantly increased 2h food intake and FOS-IR in the (b) ARC
***p≤0.0001 compared to aECF.
containing anorectic -MSH. Using FISH to identify NPY mRNA
expressing neurons and immunoﬂuorescence analysis to identify
FOS-IR neurons, approximately 32.0±2.5% of ARC NPY/AgRP neu-
rons were activated by 150nmol/min GSN (Figs. 2a and 3a–a3). In
contrast, using dual-label immunoﬂuorescence on adjacent tissue
from the same rats, less than 1% of ARC -MSH neurons were acti-
vated by GSN (150nmol/min) (Figs. 2a and 3b–b3). This resulted in
a signiﬁcant difference; NPY neurons expressed signiﬁcantly more
FOS-IR than-MSH neurons (t(3) = 11.8, p≤0.001). These data sug-
gest that GSN signiﬁcantly activates orexigenic NPY/AgRP neurons
within the ARC.
The neuropeptides ORX and MCH are expressed in the LHA
in distinct, non-overlapping populations. We performed dual-
label immunoﬂuorescence analysis to investigate the chemical
identity of LHA GSN activated neurons. We observed that GSN
(150nmol/min) induced FOS-IR in approximately 30.7±3.5% of
LHAORXneurons (Figs. 2band3c–c3),while in contrast saline treat-
ment activated less than 1%. Interestingly, GSN (150nmol/min)
did not substantially activate orexigenic MCH-containing neu-
rons; less than 1% of LHA MCH neurons co-expressed FOS-IR
(Figs. 2b and 3d–d3). This difference in GSN-stimulated ORX and
MCH FOS-IR induction was signiﬁcant (t(2) = 9.0, p≤0.01). Taken
together, these data indicate that GSN-stimulated feeding is asso-
ciated with ARC NPY/AgRP and LHA ORX neuronal activation.
We hypothesized that GSN would act to promote food intake
by stimulating GI- neurons via a GK-dependent mechanism and
predicted that this would occur via speciﬁc activation of orexi-
genic neurons. Using induction of the immediate-early gene cFOS
as an indicator of neuronal activation [21], we observed that GSN
(150nmol/min) signiﬁcantly stimulated food intake and increased
neuronal activity within discrete nuclei implicated in the central
control of feeding and glucose homeostasis, the ARC and LHA.
Consistentwith an effect onGK-mediated glucose-sensing, the pat-
tern of hypothalamic FOS-IR activation observed was similar to
that previously reported following induction of hypoglycaemia or
glucopenia [22–24]. Furthermore, we also observed a strong corre-
LHAMCH neurons. (a) In the ARC, GSN (150nmol/min, i.c.v.) induced FOS-IR in less
rons. (b) In the LHA, GSN did not increase FOS-IR in MCH-IR neurons, but produced
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Fig. 3. Colocalization of FOS-IR with ARC NPY mRNA and -MSH-IR neurons and with LHA ORX-IR and MCH-IR neurons in rats treated with GSN (150nmol/min, i.c.v.).
(a–d) are merged micrographs showing representative regions of FOS-IR and neuropeptide co-expression. (a1–a3, b1–b3, c1–c3, and d1–d3) are higher-power magniﬁcation
of boxes area in a–d, respectively, with a1, b1, c1, and d1 illustrating FOS-IR positive cells (green); a2 illustrating NPY mRNA, b2 illustrating -MSH-IR, c2 illustrating ORX-IR
and d2 illustrating MCH-IR (red); and a3, b3, c3, and d3 illustrating merged photographs. Arrows indicate colocolization. Scalebar in a, 75m, also applies to b; scalebar in c,
1 terpr
w
l
s
r
w
[
t
c
N
f
m
f
r
o
r
u
s
i
o
s
s
r
s
t00m, also applies to d; scalebar in d3, 25m, applies to all other images. (For in
eb version of the article.)
ationbetweenGSN-inducedhyperphagia and thedegreeof FOS-IR,
upporting the involvement of the identiﬁed FOS-IR positive neu-
ons in the physiological control of GK regulated food intake.
Within the ARC, we found that many neurons activated by GSN
ere NPY/AgRP, a population of neurons reported to express GK
13]. This pattern of activation is consistent with the observation
hatmost (althoughnot all) ARCneurons exhibiting suppressed cal-
ium signalling under hypoglycaemic/glucopenic conditions were
PY positive [25,26]. Previous behavioural data also support a role
or NPY neurons in the feeding response to hypoglycemiawith ani-
als genetically deﬁcient in NPY displaying reduced glucoprivic
eeding [27]. Our ﬁndingswith GSN suggest that GI-NPY/AgRP neu-
ons may use GK to detect and respond to falling glucose levels.
Within the LHA, cFOS induction by GSN was predominantly
bserved in ORX containing neurons, with less that 1% ofMCHneu-
ons exhibiting co-labelling. The activation of LHA ORX neurons
nder these conditions is consistent with previous studies demon-
trating increased cFOS speciﬁcally within these neurons upon
nsulin-induced hypoglycaemia in rats [22,28] and electrophysi-
logical investigation of ORX neuron excitability in hypothalamic
lices [4]. Given that ORX is critical for wakefulness [29], it is pos-
ible that GSN activation of this population of neurons may be
elevant tomaintaining arousal,which is necessary for food seeking
eek behaviour. We found no effect of GSN on MCH neuron activa-
ion, an observation corroborated by reports that MCH-containingetation of the references to color in this ﬁgure legend, the reader is referred to the
neurons behave differently from ORX neurons, being stimulated
rather than inhibited by glucose [4,7,28].
Taken together, our ﬁndings that GSN, a GK inhibitor, activates
NPY and ORX expressing neurons suggests that these cells may
utilise GK to detect and respond to a fall in glucose by stimulat-
ing feeding behaviour, or at very least be critical to the induction of
this counter-regulatory response as a downstream component of a
broader glucose sensing network. In light of the identiﬁcation of GK
expression within additional neuronal and non-neuronal glucose-
sensing populations [3,30,31], it is at present unclear whether NPY
and ORX cells types represent ﬁrst-order targets of GSN action.
However, our work adds to the growing body of data suggesting
that brain glucose-sensing in the hypothalamus may be akin to
peripheral glucose-sensing as mediated by GK.
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